Last updated on December 2018

A Long-Term Registry of Humira (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)


Brief description of study

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.

Clinical Study Identifier: NCT01848561

Contact Investigators or Research Sites near you

Start Over

ABBVIE CALL CENTER

London North West Healthcare N /ID# 145953
Harrow, United Kingdom
0.13miles
  Connect »

ABBVIE CALL CENTER

Imperial College Healthcare /ID# 145916
London, United Kingdom
7.43miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.